289 related articles for article (PubMed ID: 11023538)
1. NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors.
Lafuente MJ; Casterad X; Trias M; Ascaso C; Molina R; Ballesta A; Zheng S; Wiencke JK; Lafuente A
Carcinogenesis; 2000 Oct; 21(10):1813-9. PubMed ID: 11023538
[TBL] [Abstract][Full Text] [Related]
2. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.
van der Logt EM; Bergevoet SM; Roelofs HM; Te Morsche RH; Dijk Yv; Wobbes T; Nagengast FM; Peters WH
Mutat Res; 2006 Jan; 593(1-2):39-49. PubMed ID: 16039674
[TBL] [Abstract][Full Text] [Related]
3. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese.
Hamajima N; Matsuo K; Iwata H; Shinoda M; Yamamura Y; Kato T; Hatooka S; Mitsudomi T; Suyama M; Kagami Y; Ogura M; Ando M; Sugimura Y; Tajima K
Int J Clin Oncol; 2002 Apr; 7(2):103-8. PubMed ID: 12018106
[TBL] [Abstract][Full Text] [Related]
4. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population.
Sameer AS; Shah ZA; Syeed N; Rasool R; Afroze D; Siddiqi MA
Asian Pac J Cancer Prev; 2010; 11(1):209-13. PubMed ID: 20593958
[TBL] [Abstract][Full Text] [Related]
5. Association between NQO1 C609T polymorphism and colorectal cancer risk.
Wang Y; Zhang G; Luo Y
Tumour Biol; 2013 Dec; 34(6):4027-32. PubMed ID: 23893397
[TBL] [Abstract][Full Text] [Related]
6. NAD(P)H quinone oxidoreductase 1 codon 609 polymorphism and its association to colorectal cancer.
Harth V; Donat S; Ko Y; Abel J; Vetter H; Brüning T
Arch Toxicol; 2000 Jan; 73(10-11):528-31. PubMed ID: 10663383
[TBL] [Abstract][Full Text] [Related]
7. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
[TBL] [Abstract][Full Text] [Related]
8. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
[TBL] [Abstract][Full Text] [Related]
9. Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract.
Sarbia M; Bitzer M; Siegel D; Ross D; Schulz WA; Zotz RB; Kiel S; Geddert H; Kandemir Y; Walter A; Willers R; Gabbert HE
Int J Cancer; 2003 Nov; 107(3):381-6. PubMed ID: 14506737
[TBL] [Abstract][Full Text] [Related]
10. NQO1 C609T Polymorphism is Associated with Coronary Artery Disease in a Gender-Dependent Manner.
Boroumand M; Pourgholi L; Goodarzynejad H; Ziaee S; Hajhosseini-Talasaz A; Sotoudeh-Anvari M; Mandegary A
Cardiovasc Toxicol; 2017 Jan; 17(1):35-41. PubMed ID: 26690082
[TBL] [Abstract][Full Text] [Related]
11. The C609T inborn polymorphism in NAD(P)H:quinone oxidoreductase 1 is associated with susceptibility to multiple sclerosis and affects the risk of development of the primary progressive form of the disease.
Stavropoulou C; Zachaki S; Alexoudi A; Chatzi I; Georgakakos VN; Terzoudi GI; Pantelias GE; Karageorgiou CE; Sambani C
Free Radic Biol Med; 2011 Aug; 51(3):713-8. PubMed ID: 21605663
[TBL] [Abstract][Full Text] [Related]
12. NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.
Kracht T; Schrappe M; Strehl S; Reiter A; Elsner HA; Trka J; Cario G; Viehmann S; Harbott J; Borkhardt A; Metzler M; Langer T; Repp R; Marschalek R; Welte K; Haas OA; Stanulla M
Haematologica; 2004 Dec; 89(12):1492-7. PubMed ID: 15590400
[TBL] [Abstract][Full Text] [Related]
13. [The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer].
Zhang JH; Li Y; Wang R; Sarbia M; Guo W; Wen DG; Wei LZ; Chen ZF; Kuang G; Zhang LW; He M; Wu ML; Wang SJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):544-6. PubMed ID: 14669229
[TBL] [Abstract][Full Text] [Related]
14. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism.
Wiencke JK; Spitz MR; McMillan A; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):87-92. PubMed ID: 9037558
[TBL] [Abstract][Full Text] [Related]
16. [Interaction between polymorphisms in NQO1(C609T) and XRCC1(G28152A) and their correlation with smoking on gastric cancer].
Chen DJ; Ding R; Cao W; Ye DQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Jan; 32(1):5-8. PubMed ID: 21518531
[TBL] [Abstract][Full Text] [Related]
17. [Genetic polymorphisms of NQO1, GSTT1, GSTM1 and susceptibility to chronic benzene poisoning].
Chen Y; Li GL; Ji ZY; Xu JN; Wu CL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Feb; 23(1):1-5. PubMed ID: 15748501
[TBL] [Abstract][Full Text] [Related]
18. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: a meta-analysis.
Zhu CL; Huang Q; Liu CH; Lin XS; Xie F; Shao F
Asian Pac J Cancer Prev; 2013; 14(4):2349-54. PubMed ID: 23725139
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of the NQO1 C609T Polymorphism in Non Small Cell Lung Adenocarcinoma Patients.
Masroor M; Jain A; Javid J; Mir R; Prashant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7653-8. PubMed ID: 26625776
[TBL] [Abstract][Full Text] [Related]
20. A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population.
Liu F; Luo L; Wei Y; Wang W; Li B; Yan L; Wen T
Tumour Biol; 2013 Feb; 34(1):47-53. PubMed ID: 22972504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
